Of note, the expression of GABARAPL1 only predicted HCC sensitivity to erastin‐induced ferroptosis, not to RSL3‐induced ferroptosis (Fig. 6C). The gene discussed is GABARAPL1; the disease is hepatocellular carcinoma.